Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARQT | Common Stock | Purchase | $200K | +21.1K | +0.24% | $9.50 | 8.79M | Mar 4, 2024 | By Frazier Life Sciences VIII, L.P. | F1 |
holding | ARQT | Common Stock | 7 | Mar 4, 2024 | By FHM Life Sciences VIII, L.L.C. | F2 | |||||
holding | ARQT | Common Stock | 23.7K | Mar 4, 2024 | By The Heron Living Trust 11/30/2004 | F3 | |||||
holding | ARQT | Common Stock | 8.69K | Mar 4, 2024 | Direct | F4 |
Id | Content |
---|---|
F1 | The shares are held directly by Frazier Life Sciences VIII, L.P. FHM Life Sciences VIII, L.P. is the general partner of Frazier Life Sciences VIII, L.P. and FHM Life Sciences VIII, L.L.C. is the general partner of FHM Life Sciences VIII, L.P. James N. Topper and the Reporting Person are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences VIII, L.P. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
F2 | The shares are held directly by FHM Life Sciences VIII, L.L.C. James N. Topper and the Reporting Person are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences VIII, L.P. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
F3 | The shares are held directly by The Heron Living Trust 11/30/2004. The Reporting Person is the co-trustee of The Heron Living Trust 11/30/2004 and has voting and investment power of the securities held by The Heron Living Trust 11/30/2004. |
F4 | Includes 4,375 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of the Issuer's Common Stock for each one (1) RSU upon the vesting thereof. |